300 related articles for article (PubMed ID: 36280735)
21. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
[TBL] [Abstract][Full Text] [Related]
22. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
Granadillo Rodríguez M; Flath B; Chelico L
Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
[TBL] [Abstract][Full Text] [Related]
23. Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.
Koning FA; Goujon C; Bauby H; Malim MH
J Virol; 2011 Dec; 85(24):13448-52. PubMed ID: 21957290
[TBL] [Abstract][Full Text] [Related]
24. Action-at-a-distance mutations induced by 8-oxo-7,8-dihydroguanine are dependent on APOBEC3.
Fukushima R; Suzuki T; Kobayakawa A; Kamiya H
Mutagenesis; 2024 Feb; 39(1):24-31. PubMed ID: 37471265
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus and malaria upregulate AID and APOBEC3 enzymes, but only AID seems to play a major mutagenic role in Burkitt lymphoma.
Summerauer AM; Jäggi V; Ogwang R; Traxel S; Colombo L; Amundsen E; Eyer T; Subramanian B; Fehr J; Mantel PY; Idro R; Bürgler S
Eur J Immunol; 2022 Aug; 52(8):1273-1284. PubMed ID: 35503749
[TBL] [Abstract][Full Text] [Related]
26. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
27. APOBEC mutagenesis is a common process in normal human small intestine.
Wang Y; Robinson PS; Coorens THH; Moore L; Lee-Six H; Noorani A; Sanders MA; Jung H; Katainen R; Heuschkel R; Brunton-Sim R; Weston R; Read D; Nobbs B; Fitzgerald RC; Saeb-Parsy K; Martincorena I; Campbell PJ; Rushbrook S; Zilbauer M; Buczacki SJA; Stratton MR
Nat Genet; 2023 Feb; 55(2):246-254. PubMed ID: 36702998
[TBL] [Abstract][Full Text] [Related]
28. Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.
Uriu K; Kosugi Y; Suzuki N; Ito J; Sato K
J Virol; 2021 May; 95(12):. PubMed ID: 33789992
[TBL] [Abstract][Full Text] [Related]
29. APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.
Roper N; Gao S; Maity TK; Banday AR; Zhang X; Venugopalan A; Cultraro CM; Patidar R; Sindiri S; Brown AL; Goncearenco A; Panchenko AR; Biswas R; Thomas A; Rajan A; Carter CA; Kleiner DE; Hewitt SM; Khan J; Prokunina-Olsson L; Guha U
Cell Rep; 2019 Mar; 26(10):2651-2666.e6. PubMed ID: 30840888
[TBL] [Abstract][Full Text] [Related]
30. Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
Baker SC; Mason AS; Slip RG; Skinner KT; Macdonald A; Masood O; Harris RS; Fenton TR; Periyasamy M; Ali S; Southgate J
Oncogene; 2022 Apr; 41(15):2139-2151. PubMed ID: 35194151
[TBL] [Abstract][Full Text] [Related]
31. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
Wong L; Sami A; Chelico L
Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
[TBL] [Abstract][Full Text] [Related]
32. APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
DiMarco AV; Qin X; McKinney BJ; Garcia NMG; Van Alsten SC; Mendes EA; Force J; Hanks BA; Troester MA; Owzar K; Xie J; Alvarez JV
Cancer Immunol Res; 2022 Jan; 10(1):70-86. PubMed ID: 34795033
[TBL] [Abstract][Full Text] [Related]
33. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
34. Perturbation of base excision repair sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations.
Shen B; Chapman JH; Custance MF; Tricola GM; Jones CE; Furano AV
Elife; 2020 Jan; 9():. PubMed ID: 31904337
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance.
Zhu B; Xiao Y; Yeager M; Clifford G; Wentzensen N; Cullen M; Boland JF; Bass S; Steinberg MK; Raine-Bennett T; Lee D; Burk RD; Pinheiro M; Song L; Dean M; Nelson CW; Burdett L; Yu K; Roberson D; Lorey T; Franceschi S; Castle PE; Walker J; Zuna R; Schiffman M; Mirabello L
Nat Commun; 2020 Feb; 11(1):886. PubMed ID: 32060290
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.
Green AM; Weitzman MD
DNA Repair (Amst); 2019 Nov; 83():102700. PubMed ID: 31563041
[TBL] [Abstract][Full Text] [Related]
37. Molecular origins of APOBEC-associated mutations in cancer.
Petljak M; Maciejowski J
DNA Repair (Amst); 2020 Oct; 94():102905. PubMed ID: 32818816
[TBL] [Abstract][Full Text] [Related]
38. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
39. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
40. APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
Selenica P; Marra A; Choudhury NJ; Gazzo A; Falcon CJ; Patel J; Pei X; Zhu Y; Ng CKY; Curry M; Heller G; Zhang YK; Berger MF; Ladanyi M; Rudin CM; Chandarlapaty S; Lovly CM; Reis-Filho JS; Yu HA
Ann Oncol; 2022 Dec; 33(12):1284-1295. PubMed ID: 36089134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
